JOHN LYDON to Doxycycline
This is a "connection" page, showing publications JOHN LYDON has written about Doxycycline.
Connection Strength
2.003
-
A Mouse Model for Conditional Expression of Activated ?-Catenin in Epidermal Keratinocytes. Transgenic Res. 2024 Oct; 33(5):513-525.
Score: 0.873
-
Histopathologic and transcriptomic phenotypes of a conditional RANKL transgenic mouse thymus. Cytokine. 2022 12; 160:156022.
Score: 0.765
-
A bioluminescence reporter mouse that monitors expression of constitutively active ?-catenin. PLoS One. 2017; 12(3):e0173014.
Score: 0.130
-
A mouse transgenic approach to induce ?-catenin signaling in a temporally controlled manner. Transgenic Res. 2011 Aug; 20(4):827-40.
Score: 0.085
-
Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J. 2010 Nov; 24(11):4408-19.
Score: 0.082
-
Targeting reverse tetracycline-dependent transactivator to murine mammary epithelial cells that express the progesterone receptor. Genesis. 2007 Oct; 45(10):639-46.
Score: 0.068